Pneumocystis carinii pneumonia in patients with connective tissue disease.

scientific article

Pneumocystis carinii pneumonia in patients with connective tissue disease. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1097/01.RHU.0000221794.24431.36
P698PubMed publication ID16755237

P2093author name stringJian Li
Wei-Gang Fang
Xiao-Ming Huang
Xue-Jun Zeng
P433issue3
P921main subjectPneumocystis cariniiQ2099992
pneumoniaQ12192
P304page(s)114-117
P577publication date2006-06-01
P1433published inJournal of Clinical RheumatologyQ15766312
P1476titlePneumocystis carinii pneumonia in patients with connective tissue disease.
P478volume12

Reverse relations

cites work (P2860)
Q45763211A dose-escalation regimen of trimethoprim-sulfamethoxazole is tolerable for prophylaxis against Pneumocystis jiroveci pneumonia in rheumatic diseases
Q37947196Clinical conditions associated with PCP in children.
Q80199686Comparison of trimethoprim-sulfamethoxazole and aerosolized pentamidine for primary prophylaxis of Pneumocystis jiroveci pneumonia in immunocompromised patients with connective tissue disease
Q38692232Current and emerging treatment options for interstitial lung disease in patients with rheumatic disease
Q38084889Diagnosis and management of infectious complications of childhood rheumatic diseases
Q38149856Infection risk in systemic lupus erythematosus patients: susceptibility factors and preventive strategies
Q38794907Pneumocystis Pneumonia and the Rheumatologist: Which Patients Are At Risk and How Can PCP Be Prevented?
Q35793693Pneumocystis Pneumonia in Patients with Autoimmune Diseases: A Retrospective Study Focused on Clinical Characteristics and Prognostic Factors Related to Death
Q38786977Pneumocystis jiroveci pneumonia in patients treated with systemic immunosuppressive agents for dermatologic conditions: a systematic review with recommendations for prophylaxis
Q38221817Pneumocystis jirovecii pneumonia in mycophenolate mofetil-treated patients with connective tissue disease: analysis of 17 cases
Q36948496Prophylaxis against Pneumocystis pneumonia in patients with inflammatory bowel disease: toward a standard of care
Q54052789Pulmonary involvement of systemic lupus erythematosus: analysis of 90 necropsies.
Q37597971Red fist and muscle weakness with a rare complication
Q46337694Risk factors of Pneumocystis jeroveci pneumonia in patients with systemic lupus erythematosus
Q39062899The role of CD4 cell count as discriminatory measure to guide chemoprophylaxis against Pneumocystis jirovecii pneumonia in human immunodeficiency virus-negative immunocompromised patients: A systematic review

Search more.